Subscribe To
Siren biotechnology awarded $4m in grant funding from the california institute for regenerative medicine (cirm)
SAN FRANCISCO, Nov. 01, 2023 (GLOBE NEWSWIRE) — Siren Biotechnology, a gene therapy company pioneering Universal AAV Immuno-Gene Therapies for Cance...
November 1, 2023, 4:46 pm
Cellectis to report third quarter 2023 financial results on november 6, 2023
NEW YORK, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology compa...
November 1, 2023, 4:30 pm
Gracell biotechnologies to participate in four upcoming investor conferences
SAN DIEGO and SUZHOU, China and SHANGHAI, China, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDA...
November 1, 2023, 4:00 pm
Industrial agitator market revenue to cross usd 25.21 billion by 2031, registering at a cagr of 4.2% says, transparency market research
The biotechnology sector has been growing rapidly, and this has led to an increased need for specialized agitators for bioprocessing applications, suc...
November 1, 2023, 3:47 pm
Exclusive: novo hires fujifilm unit to help make wegovy weight-loss drug - source
Novo Nordisk has hired FUJIFILM Diosynth Biotechnologies to fill Wegovy injection pens, a source familiar with the matter told Reuters, as the Danish ...
November 1, 2023, 1:14 pm
Seagen 3q revenue beat driven by jump in product sales
Seagen reported mixed third quarter earnings, with revenue outperforming expectations on strong product sales growth as earnings fell short of estimat...
November 1, 2023, 12:11 pm
Sensei biotherapeutics appoints stephanie krebs, ms, mba, as chief business officer
BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discov...
November 1, 2023, 11:30 am
Celcuity to present at upcoming stifel and jefferies investor conferences
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted ...
November 1, 2023, 11:05 am
Genetic toxicology testing market expected to reach a market value of us$ 4.56 billion: growing demand for personalized medicine spurs growth, according to persistence market research
The global genetic toxicology testing market is expected to grow rapidly in the coming years, driven by increasing demand from the pharmaceutical and ...
November 1, 2023, 10:04 am
Tearsolutions, inc. appoints robert dempsey to its board of directors
Dempsey brings worldwide Ophthalmology leadership experience in driving successful drug development CHARLOTTESVILLE, Va., Nov. 01, 2023 (GLOBE NEWSWIR...
November 1, 2023, 10:00 am
Anaptys announces participation in november investor conferences
SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative ...
November 1, 2023, 9:15 am
Zymeworks announces participation in upcoming investor conferences
VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...
November 1, 2023, 8:30 am
Aptevo to present at bio-europe conference
SEATTLE, WA / ACCESSWIRE / November 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing nov...
November 1, 2023, 7:45 am
Celcuity to present at upcoming stifel and jefferies investor conferences
MINNEAPOLIS, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted t...
November 1, 2023, 7:05 am
Astrazeneca inks gene editing deal that could end up costing it $2.5bn
AstraZeneca PLC (LSE:AZN) has entered into a partnership and investment deal with French gene editing specialist ...
November 1, 2023, 3:59 am
Astrazeneca signs drug development deal with biotech cellectis
AstraZeneca said on Wednesday it had entered into a collaboration and investment agreement with clinical-stage biotechnology company Cellectis to spee...
November 1, 2023, 3:17 am
Pfizer to sees no major m&a activity in 2024: ceo bourla
Pfizer Chairman and CEO Albert Bourla says the company is still in the market for acquisitions following its $43 billion acquisition of cancer ...
October 31, 2023, 3:30 pm
Crsp stock halt: crispr trading halted ahead of fda decision
Among the more prominent gene-editing stocks on the market, investors in this space pay particularly close attention to CRISPR Therapeutics (NASDAQ: C...
October 31, 2023, 2:11 pm
Amicus therapeutics: the right play now
Amicus Therapeutics, Inc. is a commercial-stage biotech company focused on developing therapies for rar...
October 31, 2023, 12:24 pm
Innovation could propel biotechnology bounce
Biotechnology is certainly on the list, if not at the top, of high-growth industries in dire need of a rebound. Following enthusiasm for COVID-19 vacc...
October 31, 2023, 11:28 am